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ABSTRACT Stimulation of cell behavioral functions by ligand/receptor binding can be accomplished in autocrine fashion, where cells
secrete ligand capable of binding to receptors on their own surfaces. This proximal secretion of autocrine ligands near the surface
receptors on the secreting cell suggests that control of these systems by inhibitors of receptor/ligand binding may be more difficult than
for systems involving exogenous ligands. Hence, it is of interest to predict the conditions under which successful inhibition of cell
receptor binding by the autocrine ligand can be expected.
Previous theoretical work using a compartmentalized model for autocrine cells has elucidated the conditions under which addition of
solution decoys for the autocrine ligand can interrupt cell receptor/ligand binding via competitive binding of the secreted molecules
(Forsten, K. E., and D. A. Lauffenburger. 1992. Biophys. J. 61:1-12.) We now apply a similar modeling approach to examine the addition
of solution blockers targeted against the cell receptor. Comparison of the two alternative inhibition strategies reveals that a significantly
lower concentration of receptor blockers, compared to ligand decoys, will obtain a high degree of inhibition. The more direct interruption
scheme characteristic of the receptor blockers may make them a preferred strategy when feasible.
INTRODUCTION
Cell surface receptors bind corresponding ligand mole-
cules from the surrounding medium to initiate a se-
quence of events resulting in a cell behavioral response
such as proliferation, adhesion, or motility. Such recep-
tor-mediated responses can be influenced by the source
and transport properties of the ligand. Cells that synthe-
size and secrete ligand molecules, and then bind and re-
spond to them, are termed autocrine cells (Sporn and
Todaro, 1980). Acquisition of the ability to produce
their own signals may be one means by which cells be-
come transformed and lose normal regulatory control
(Huang et al., 1984; Imanishi et al., 1989; Partridge et
al., 1989; Yamada and Serrero, 1988).
Cell surface receptor/ligand complexes are typically
the signal-generating species, though in some systems,
intracellular complexes may generate the key signals
from autocrine ligands (e.g., Williams, 1989). The prox-
imal relationship between the secreted ligand and its tar-
get receptor on an autocrine cell makes signal inhibition
a particularly difficult procedure. Interruption of the
surface signaling compound may be aimed at either the
cell receptor or the autocrine ligand. Both approaches
have been attempted in vitro with some limited success
(Sato et al., 1983; Cuttitta et al., 1985; Imanishi et al.,
1989; Rodeck et al., 1990).
Previous theoretical work has addressed the issues of
competing soluble receptors in a nonautocrine cell situa-
tion (Goldstein et al., 1989), inoculum cell density ef-
fects with autocrine cells (Lauffenburger and Cozens,
1989), and the role of autocrine cells in tumor growth
(Michelson and Leith, 1991) . Our interest has been to
develop mathematical models which can be used to in-
vestigate inhibition of autocrine-ligand/cell-receptor
complexes by including inhibitory molecules in the
model framework.
An analysis ofthe effect ofsolution decoys for an auto-
crine ligand on cell surface receptor binding revealed
that effective inhibition of autocrine ligand/receptor
surface complexes may require surprisingly high concen-
trations ofthese decoys, with the required concentration
dependent on ligand transport properties (Forsten and
Lauffenburger, 1992). Using a similar modeling ap-
proach, we now present comparative results for the effect
of receptor blockers on autocrine complex formation.
We find that significantly lower concentrations ofinhibi-
tors can lead to inhibition of complex formation when
attempted via direct receptor blocking rather than by
trapping the ligand with solution decoys. This result is
not necessarily intuitive, since transport limitations cou-
pled with transient binding and depletion considerations
could hinder blockers' effectiveness in competing with
the secreted ligand for cell surface receptor binding.
MATHEMATICAL MODEL
A full description of our autocrine cell model was pre-
sented previously for the case in which ligand decoys
have been added to the surrounding medium (Forsten
and Lauffenburger, 1992). A schematic of the current
receptor blocker model is shown in Fig. 1, with the corre-
sponding differential equations, initial conditions, and
an explanation of variables and parameters provided in
the Appendix. In both models, diffusional transport and
reversible binding between the added inhibitor and its
target molecule are included as is autocrine ligand secre-
tion and reversible binding of the ligand to the cell sur-
face receptor. To explore a realistic example, parameter
values for interleukin 2 and its high-affinity receptor are
used, as previously (Forsten and Lauffenburger, 1992).
Receptor blockers are assumed to have the same affinity
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duced. Higher levels of ligand are available for binding
and the level of surface complexes is thus, limited by
receptor synthesis and endocytosis. At lower cell densi-
ties, the available ligand for binding is reduced such that
it becomes a limiting factor for the level of surface com-
plexes. Initiation of inhibition comes when receptor
blockers can begin to compete with ligand for the avail-
able receptors. This is similar to the initial inhibition
threshold response exhibited in the presence of ligand
decoys (Fig. 2 B). The decoys begin to affect complex
A
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FIGURE I Diagram of model. Complete description of variables and
parameters is included in the Appendix.
for the receptor as does the ligand. Values of the inhibi-
tor's affinity for the receptor and its diffusion constant
are varied to investigate property effects of the competi-
tive inhibitors.
A transient solution of the system of coupled nonlin-
ear equations was sought and obtained using LSODE, an
implicit solver (Hindmarsh, 1980). Initial conditions
used correspond to the initial moment of both secretion
and the addition ofreceptor blockers. Hence, initially all
surface receptors are unbound and unblocked (see Ap-
pendix). Inhibition plots found in Figs. 2 and 3 reflect
the level of surface complexes found at the end of30 h of
both autocrine secretion and inhibitor exposure with the
complex level being scaled by the number of surface re-
ceptors found in the absence of autocrine ligand secre-
tion or receptor blocker exposure.
RESULTS AND DISCUSSION
Our foremost objective was to determine the concentra-
tion of receptor blockers needed to substantially prevent
autocrine ligand-receptor binding, and to compare this
result to that previously obtained for ligand decoys by
Forsten and Lauffenburger (1992). As shown in Fig. 2
A, low concentrations of receptor blockers have essen-
tially no effect upon the level of surface complexes after
30 h ofboth ligand secretion and blocker exposure. Once
a threshold concentration of inhibitor molecules has
been added, surface complexes are reduced with increas-
ing concentration ofinhibitor until near complete elimi-
nation of surface complexes is obtainable. The threshold
concentration of blockers required to initiate inhibition
is dependent on cell density. Essentially, at high cell den-
sities in the absence ofinhibitor, cell separation distances
are sufficiently small that gradients driving the ligand
flux away from the cell's immediate surrounding are re-
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FIGURE 2 Effect of cell density. (A) Receptor blocker addition. Effect
of increasing concentrations ofreceptor blockers on the level ofsurface
complexes at various cell densities is shown. Surface ligand/receptor
complexes, C, are scaled by Ro, the level of surface receptors found in
the absence of ligand secretion. The total concentration of receptor
blockers added to the cell environment, Bt, has been plotted logarithmi-
cally for visual ease. (B) Ligand decoy addition. The effect ofincreasing
concentrations ofligand decoys on the level ofscaled surface ligand/ re-
ceptor complexes is shown as a function ofcell density. Calculations for
both inhibitor systems used the following interleukin-2 parameter val-
ues: kon = 3.1. 107 M-l S-', kff= 2.3 * 10-4 1', kBn =ks =k, kBff=
ksff = k0ff, Ro = 2,000 receptors/cell, k, = 0.0046 min-', V, = Ro*k,,
kI = 0.046 min-', k, = 0.0046 min-', DL = 10-6cm2/s, DB = 4.0 * 10-7
cm2/s, Q = 500 molecules/min, a = 5 ,um, 6 = 0.2 Am. For all subse-
quent figures, 105 cells/ml is the standard density used.
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FIGURE 3 Direct comparison of inhibition schel
surface ligand/receptor complexes as a function
tration for both receptor blockers and ligand deco
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quired to initiation reduction in surface comple
order of magnitude less than that required by ligar
over 99% inhibition of surface complexes, the reqi
differ by nearly four orders of magnitude. Param
with Fig. 2.
formation when their concentration is
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Given the parameters of our exampl
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old concentrations required by the
schemes can differ by about an order of
3). At a cell density of 105 cells/ml, a c
4* 10-10 M ligand decoys would be req
surface ligand/ receptor complex inhibi
concentration of only 1 * 10-" M re
could achieve the same initial inhibition
ofdecoys by ligand binding in the bulk n
with diffusion limitations for decoy trz
secretion layer, causes an increase in the
centration which must be added to the ;
inhibition by decreasing the level of a
within the secretion layer. Receptor blo
secretion layer directly interrupt ligan(
plex formation via receptor blocking,
blockers merely acting as a reservoir; a 4
limitation for movement into the secreti
ists for the blockers but the overall effi
compromised by events far from the ce]
More importantly, the inhibitor cc
quired to achieve almost complete inhit
ofmaximum possible surface complexes
ically lower for receptor blockers than fi
(Fig. 3). At a cell density of 105 cells,
calculations indicate a concentration
3 * 10
-7M for the receptor blockers as ol
centration requirement of 1 * I0O- M fo:
coys. However, with receptor blockers,
tion required is cell density dependent'
case for the ligand decoys (see Fig. 2, A and B). Bulk
medium influences are primarily responsible for these
differences. Ligand decoys trap secreted ligand within
the bulk medium, thereby increasing the gradient driv-
- ligand decoys ing the ligand from the cell surface and, further, prevent-
- receptor blockers ing the bulk ligand from diffusing to neighboring cells.
Once the concentration of added decoys is sufficiently
great to deplete the bulk ligand, a transport-limited re-
gime in which further addition of decoys has essentially
no effect on surface complex levels is exhibited (see Fig. 2
B). Newly-secreted ligand is still capable of binding to
the surface receptors, so it is only when the concentra-
tion of ligand decoys close to the cell surface is high
enough to directly compete with the surface receptors
mes. Level of scaled that further inhibition of surface complexes can be ob-
of inhibitor concen- tained. With receptor blockers as the inhibiting mole-
ys is shown for a cell
cules the transport-limited plateau and secondaryeceptor blockers re-
t
x levels is about an threshold concentration characteristic of the ligand de-
id decoys. To obtain coy inhibition profile are eliminated. Here, bulk me-
uired concentrations dium interactions have no role in the process. When the
eter values are listed concentration of receptor blockers within the secretion
layer is high enough to bind available cell receptors, sur-
face complexes are essentially eliminated. The required
concentration is dependent on the ligand concentration
high enough to and, hence, is cell density dependent.
I. It is the transport-limited regime aspect of inhibition
le system (inter- which truly distinguishes between the inhibitory
-he initial thresh- schemes. While transport properties of the ligand, as
two inhibition characterized by its diffusion coefficient, have a strong
magnitude (Fig. effect upon the level of inhibition obtainable with the
concentration of ligand decoys, no effect upon the receptor blockers inhi-
juired to initiate bition profile is exhibited (not shown). The affinity of
ition, whereas a the ligand for the cellular receptor has essentially the
ceptor blockers same effect for both inhibitory schemes-the association
level. Depletion rate constant has a much more pronounced effect than
iedium, coupled the dissociation rate constant (not shown). However,
ansport into the the level of inhibition attainable within the transport-
total decoy con- limited regime is significantly influenced by the recep-
system to obtain tor-ligand affinity when ligand decoys are added, but,
ivailable decoys again, this characteristic region is not evident with the
ickers within the receptor blockers (Forsten and Lauffenburger, 1992).
d-receptor com- The characteristics of the inhibitory molecule itself
with bulk phase have roughly the same effect on the inhibition profiles in
similar diffusion each scheme. The transport of the inhibitor, as charac-
ion layer still ex- terized by its diffusion coefficient, has no effect on the
zctiveness is not inhibition profile in either case (not shown). The inhibi-
11 surface. tor's affinity for either the receptor or the ligand, depend-
mncentration re- ing on the scheme examined, has a small effect on both
)ition (e.g., <1% the concentration required to obtain initial inhibition
) can be dramat- and the subsequent concentration required to eliminate
or ligand decoys surface complexes. With the ligand decoys, the associa-
/ml, our model tion rate constant has a much more dramatic effect on
requirement of the inhibition profile than the dissociation rate constant,
pposed to a con- while it is the overall affinity change, not the individual
r the soluble de- rates, that influences the receptor blocker profile (not
, the concentra- shown). For the decoys, complete inhibition occurs
which is not the when the secretion layer molecules are able to compete
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higher concentrations requirements to initiate inhibition
for both schemes, but the concentration required to ob-
tain near complete inhibition is only increased for the
receptor blockers. The concentration of ligand decoys
required to directly compete with the surface receptors is
so high that any time-dependent binding depletion is in-
significant. It is important to note that the assumption of
no degradation of either ligand or inhibitor in solution
may be inappropriate for long time spans, but the key
result that receptor blockers offer a better means ofcom-
plex inhibition should still hold.
-5 -1 SUMMARY
-5
F1GURE 4 Inhibition ofsurface complexes as a function oftime (A/B)
(receptor blockers/ligand decoys). Scaled level of surface ligand/re-
ceptor complexes present as a function ofboth the total concentration
of inhibitor added and the time following initiation of secretion and
inhibitor addition. Parameter values are listed with Fig. 2.
and absorb all available ligand, even those newly se-
creted. It is the initial binding which is paramount. With
the receptor blockers, ligand is readily available for bind-
ing and it is the hold ofthe receptor blocker on the recep-
tor which is critical; the dissociation and association
rates are both important.
In accord with our earlier work (Forsten and Lauffen-
burger, 1992), transient solutions rather than steady-
state solutions were sought with time zero representing
the simultaneous initiation ofsecretion and inhibitor ad-
dition. Receptor blockers can be removed from the cell
environment via endocytosis whereas no degradation of
either inhibitor while in solution is included. Hence, de-
pletion of receptor blockers but not ligand decoys can
potentially occur. However, given the parameter choices
of our system, significantly lower concentrations of re-
ceptor blockers are still required to obtain near complete
surface complex inhibition even after 30 d of exposure
(Fig. 4, A and B). Increasing the time span does result in
An autocrine cell model has been developed which incor-
porates the addition ofmolecules aimed at interrupting a
cell surface ligand-receptor interaction via blockage of
the receptor binding site. To facilitate calculations, a sim-
ple compartmentalized model was developed in which
all spatial variations were limited to two length scales: a
short range cellular binding region and a bulk fluid
phase. A similar approach was used previously to de-
velop an autocrine cell model which incorporated decoy
molecules capable of interrupting the surface complex
by drawing secreted ligand away from the cell surface
(Forsten and Lauffenburger, 1992).
Analysis reveals that receptor blockers may be more
efficient, by one to a few orders of magnitude in concen-
tration, in eliminating autocrine ligand/cell receptor
complexes than are ligand decoys. Further, the inhibi-
tion profile for the blockers is quite distinct from the
complex inhibition profile for the decoys. Decoys exhibit
a transport-limited regime which is not evident for re-
ceptor blockers. Consequently, the diffusional transport
of the autocrine ligand has essentially no effect on the
blocker's inhibition profile while it does have a signifi-
cant influence on that of the decoys. Variations in other
system parameters, including characteristics ofthe inhib-
itor molecule itself, have similar affects in both systems.
The important findings from these studies are predic-
tions for the concentrations of inhibitory molecules
needed for prevention of cell surface binding by secreted
ligands, and an understanding ofhow key system param-
eters influence the required levels. It has been shown that
both receptor blockers and ligand decoys can be success-
fully used for this purpose, but that receptor blockers
may require significantly lower concentrations to obtain
an equivalent degree of surface complex inhibition. By
interacting directly with the cell receptors, blockers by-
pass bulk medium interactions which serve to diminish
the effectiveness of ligand decoys. This advantage pre-
dominates over the diffusion limitations that retard the
transport of both blockers and decoys into the secretion
layer, leading to the prediction that receptor blockers
should be preferred to ligand decoys for efficiency in sur-
face receptor/ligand complex inhibition.
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APPENDIX
The autocrine cell model basis is a suspension cell of radius a which is
secreting ligand at a constant rate Q. Receptors are synthesized at a rate
V, and homogeneously distributed over the surface. In the absence of
ligand secretion, Ro receptors are found on the cell surface. Newly se-
creted ligand is released into a secretion layer surrounding the cell of
volume V* and thickness 5. Ligand within this layer, L*, is capable of
binding reversibly with free cell receptors, R, to form receptor-ligand
complexes, C. This binding is characterized by rate constants k0. and
k,ff. Internalization of both bound and unbound receptors can occur
and is characterized by rate constants k1 and kt, respectively. Unbound
receptor blockers are assumed to be initially uniformly distributed
throughout the extracellular fluid phase. Blockers within the secretion
layer, B*, are capable of reversibly binding to unbound cell receptors
with this binding being characterized by rate constants kon and koff.
Receptor-receptor blocker complexes, Y, are internalized with rate
constant k, which may differ from both the constitutive and endocytic
rate constants k, and ke,. Diffusion ofboth ligand and receptor blockers
between the secretion layer and the bulk fluid phase is characterized by
the Smoluchowski diffusion-controlled rate constant to a sphere (Smo-
luchowski, 1917). The model is written on a per cell basis with all cells
assumed to be uniformly distributed and all transport of bulk fluid
phase ligand and receptor blockers, LB and BB, respectively, between
neighboring cell regions being reciprocated.
The seven ordinary differential equations describing the model are
listed below. The initial conditions used to solve the system of equa-
tions follow. Parameter values choices are listed with Fig. 2 with selec-
tion references listed elsewhere (Forsten and Lauffenburger, 1992).
dt = konL*R + koffC-k B*R+ koffY
dC
=k L*R- koffC - keC
V* dt -kB B*R -4kYBY+ AB(BB-B*)
V dt o f
dY k BB*R- kffY- k,jY
V*dL*V* dt =-konL*R + koffC + AL(LB L*) + Qdt
VB dtB _-AL(LBL)
dBB
VB dtB -AB(BB -B*),
where:
AL 4irDL(a + 6) AB = 4rDB(a + 6)
R C Y
-= I -= O-=0Ro Ro Ro
B* BB
=1
-=1Bt Bt
-- 0 LB 0
KD D
where B, is the concentration of receptor blockers added and KD is the
equilibrium dissociation constant, koff/kon, for the ligand-cell receptor
complexes.
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